Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction

World Journal of Surgery

Volumn 27, Issue 9, 2003, Pages 1021-1025

  Tytgat, Guido N J ^a   Van Sandick, Johanna W ^a   Van Lanschot, J Jan B ^a   Obertop, Huug ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; ECONOMICS; ENDOSCOPIC BIOPSY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS TUMOR; HEALTH SURVEY; HISTOLOGY; HUMAN; INTESTINE; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; METAPLASIA; MORTALITY; PATHOLOGY; REVIEW;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; ESOPHAGOSCOPY; HUMANS; INTESTINES; METAPLASIA; POPULATION SURVEILLANCE;

EID: 0141765756     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7194-2     Document Type: Review

References (59)

1. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J.A.M.A. 1991;265:1287-1289
2. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-513
3. Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Gastroenterology 1996;110:A7
4. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum. Pathol. 1988;19:942-948
5. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum. Pathol. 1994;25:982-983
6. Ireland AP, Clark GWB, DeMeester TR. Carcinoma of the cardia: role of short-segment Barrett's esophagus and columnar metaplasia. Dis. Esoph. 1996;9:159-160
7. Schnell TG, Sontag SJ, Chejfec G. Adenocarcinoma arising in tongues or short segments of Barrett's esophagus. Dig. Dis. Sci. 1992;37:137-143
8. Clark GWB, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinoma of the cardia? Arch. Surg. 1994;129:609-614
9. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541-1546
10. Morales TG, Sampliner RE, Hhattacharyya A. Intestinal metaplasia of the gastric cardia. Am. J. Gastroenterol. 1997;92:414-418
11. Stein HJ, Barlow AP, DeMeester TR, et al. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann. Surg. 1992;216:35-43
12. Cameron AJ, Kamath PS, Carpenter HA. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology 1997;112:A82
13. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am. J. Gastroenterol. 1997;92:212-215
14. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-1536
15. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine biopsy. Am. J. Gastroenterol. 1996;91:1507-1511
16. Hirota WK, Loughney TM, Lazas DJ, et al. The prevalence, clinical characteristics and incidence of dysplasia in short segment Barrett's esophagus: a prospective cohort of 889 patients. Gastroenterology 1997;112:A577
17. Chalasani N, Wo JM, Hunter JG, et al. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig. Dis. Sci. 1997;42:603-607
18. Streitz JM, Ellis FH, Gibb SP, et al. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann. Surg. 1991;213:122-125
19. Menke-Pluymers MBE, Schoute NW, Mulder AH, et al. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992;33:1454-1458
20. Duhaylongsod FG, Wolfe WG. Barrett's esophagus and adenocarcinoma of the esophagus and gastroesophageal junction. J. Thorac. Cardiovasc. Surg. 1991;102:36-41
21. Lerut T, Coosemans W, Van Raemdonck D, et al. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J. Thorac. Cardiovasc. Surg. 1994;107:1059-1066
22. Tytgat GNJ, Hameeteman W, Onstenk R, et al. The spectrum of columnar-lined esophagus-Barrett's esophagus. Endoscopy 1989;21:177-185
23. McClave SA, Boyce HW, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest. Endosc. 1987;33:413-416
24. Tytgat GNJ. Endoscopic diagnosis of columnar-lined esophagus. Motility 1989;7:14-15
25. Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest. Endosc. 1996;44:91-95
26. Riddell RH. Early detection of neoplasia of the esophagus and gastroesophageal junction. Am. J. Gastroenterol. 1996;91:853-863
27. Weston AP, Krmpotich P, Makdisi WF, et al. Short segment Barrett's esophagus: clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am. J. Gastroenterol. 1996;91:981-986
28. Clark GWB, Ireland AP, Peters JH, et al. Short-segment Barrett's esophagus: a prevalent complication of gastroesophageal reflux disease with malignant potential. J. Gastrointest. Surg. 1997;1:113-122
29. Abo SR, Stevens PD, Abedi M, et al. Prevalence of short-segment Barrett's epithelium in patients with gastroesophageal reflux disease. Gastroenterology 1995;108:A43
30. Heier SK, Seif F, Webber S, et al. Short segment Barrett's esophagus: clinical and histologic findings. Gastroenterology 1996;110:A132
31. Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barrett's esophagus: prevalence, diagnosis and associations. Gut 1997;40:710-715
32. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991;32:1441-1446
33. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212-1219
34. Polkowski W, Van Lanschot JJB, Ten Kate FJW, et al. The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg. Oncol. 1995;4:163-171
35. Tytgat GNJ, Hameeteman W. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J. Surg. 1992;16:308-312
36. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-1256
37. Levine DS, Haggitt RC, Irvine S, et al. Natural history of high-grade dysplasia in Barrett's esophagus. Gastroenterology 1996;110:A550
38. Levine DS, Haggitt RC, Blount PL, et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50
39. Peters JH, Clark GWB, Ireland AP, et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J. Thorac. Cardiovasc. Surg. 1994;108:813-821
40. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am. J. Gastroenterol. 1993;88:1832-1836
41. Obertop H, Poen H, Kooijman CD. Carcinoom in een vroeg stadium in de Barrett-oesofagus: toevallige vondst of speurwerk? Ned. Tjidschr. Geneeskd. 1993;137:436-439
42. Pera M, Trastek VF, Carpenter HA, et al. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann. Thorac. Surg. 1992;54:199-204
43. Edwards MJ, Dennis RG, Lentsch BS, et al. The rationale for esophagectomy as optimal therapy for Barrett's esophagus with high grade dysplasia. Ann. Surg. 1996;223:585-589
44. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann. Surg. 1996;224:66-71
45. Cameron AJ, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am. J. Gastroenterol. 1997;92:586-591
46. Chobanian SJ, Cattau EL, Winters C, et al. In vivo staining with toluidine blue as an adjunct to the endoscopic detection of Barrett's esophagus. Gastrointest. Endosc. 1987;33:99-101
47. Canto M, Setrakian S, Chak A, et al. Methylene blue-directed biopsy for improved detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a controlled sequential trial. Gastrointest. Endosc. 1996;43:A165
48. Stein HJ. Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth world congress of the International Society for Diseases of the Esophagus. Dis. Esoph. 1996;9:S3
49. McArdle JE, Lewin KL, Randall G, et al. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum. Pathol. 1992;23:479-482
50. Nishimaki T, Hölscher AH, Schüler M, et al. Histopathologic characteristics of early adenocarcinoma in Barrett's esophagus. Cancer 1991; 68:1731-1736
51. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90
52. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum. Pathol. 1988;19:166-178
53. Achkar E, Carey W. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. Am. J. Gastroenterol. 1988;83:291-294
54. Wright TA, Gray MR, Morris AI, et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996;39:574-579
55. Sonnenberg A, EI-Serag HB. Cost-effectiveness of endoscopic screening. Gastroenterology 1997;112:A660
56. Streitz JM, Ellis FH, Tilden RL, et al. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with screening mammography. Am. J. Gastroenterol. 1996;91:A71
57. Provenzale D, Kemp JA, Arora S, et al. A guide for surveillance of patients with Barrett's esophagus. Am. J. Gastroenterol. 1994;89:670-680
58. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett's esophagus. Does it help? J. Thorac. Cardiovasc. Surg. 1993;105:383-387
59. Cole P, Morrison AS. Basic issues in population screening for cancer. J. Natl. Cancer Inst. 1980;64:1263-1272